1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Respiratory Disease Testing & Diagnostics Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-14W6096
Home | Market Reports | Health| Health Conditions
Global Respiratory Disease Testing Diagnostics Market Insights and Forecast to 2028
BUY CHAPTERS

Global Respiratory Disease Testing & Diagnostics Market Research Report 2025

Code: QYRE-Auto-14W6096
Report
September 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Respiratory Disease Testing & Diagnostics Market Size

The global market for Respiratory Disease Testing & Diagnostics was valued at US$ 4700 million in the year 2024 and is projected to reach a revised size of US$ 5341 million by 2031, growing at a CAGR of 1.9% during the forecast period.

Respiratory Disease Testing & Diagnostics Market

Respiratory Disease Testing & Diagnostics Market

Respiratory measuring devices, also known as respirometers, include respirometers, pulse oximeters, carbonic acid meters, and peak flow meters.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Respiratory Disease Testing & Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Disease Testing & Diagnostics.
The Respiratory Disease Testing & Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Respiratory Disease Testing & Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Disease Testing & Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Respiratory Disease Testing & Diagnostics Market Report

Report Metric Details
Report Name Respiratory Disease Testing & Diagnostics Market
Accounted market size in year US$ 4700 million
Forecasted market size in 2031 US$ 5341 million
CAGR 1.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Imaging Test
  • Respiratory Measurement
  • Blood Gas Test
  • Other
Segment by Application
  • Hospitals
  • Physician Clinics
  • Clinical Laboratories
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Becton Dickinson, Abbott Laboratories, Abbott, Cepheid, Fischer and Paykel, Futuremed, Hoffmann-La Roche, Instrumentation Laboratories, Medtronic, NDD Medical Technologies, Nihon Kohden, Philips Medical Systems, SDI Diagnostics, Seegene, Smiths Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Respiratory Disease Testing & Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Respiratory Disease Testing & Diagnostics Market growing?

Ans: The Respiratory Disease Testing & Diagnostics Market witnessing a CAGR of 1.9% during the forecast period 2025-2031.

What is the Respiratory Disease Testing & Diagnostics Market size in 2031?

Ans: The Respiratory Disease Testing & Diagnostics Market size in 2031 will be US$ 5341 million.

Who are the main players in the Respiratory Disease Testing & Diagnostics Market report?

Ans: The main players in the Respiratory Disease Testing & Diagnostics Market are Becton Dickinson, Abbott Laboratories, Abbott, Cepheid, Fischer and Paykel, Futuremed, Hoffmann-La Roche, Instrumentation Laboratories, Medtronic, NDD Medical Technologies, Nihon Kohden, Philips Medical Systems, SDI Diagnostics, Seegene, Smiths Medical

What are the Application segmentation covered in the Respiratory Disease Testing & Diagnostics Market report?

Ans: The Applications covered in the Respiratory Disease Testing & Diagnostics Market report are Hospitals, Physician Clinics, Clinical Laboratories, Other

What are the Type segmentation covered in the Respiratory Disease Testing & Diagnostics Market report?

Ans: The Types covered in the Respiratory Disease Testing & Diagnostics Market report are Imaging Test, Respiratory Measurement, Blood Gas Test, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Disease Testing & Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Imaging Test
1.2.3 Respiratory Measurement
1.2.4 Blood Gas Test
1.2.5 Other
1.3 Market by Application
1.3.1 Global Respiratory Disease Testing & Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Physician Clinics
1.3.4 Clinical Laboratories
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Disease Testing & Diagnostics Market Perspective (2020-2031)
2.2 Global Respiratory Disease Testing & Diagnostics Growth Trends by Region
2.2.1 Global Respiratory Disease Testing & Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Respiratory Disease Testing & Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Respiratory Disease Testing & Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Respiratory Disease Testing & Diagnostics Market Dynamics
2.3.1 Respiratory Disease Testing & Diagnostics Industry Trends
2.3.2 Respiratory Disease Testing & Diagnostics Market Drivers
2.3.3 Respiratory Disease Testing & Diagnostics Market Challenges
2.3.4 Respiratory Disease Testing & Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Disease Testing & Diagnostics Players by Revenue
3.1.1 Global Top Respiratory Disease Testing & Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Respiratory Disease Testing & Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Respiratory Disease Testing & Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Respiratory Disease Testing & Diagnostics Revenue
3.4 Global Respiratory Disease Testing & Diagnostics Market Concentration Ratio
3.4.1 Global Respiratory Disease Testing & Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Disease Testing & Diagnostics Revenue in 2024
3.5 Global Key Players of Respiratory Disease Testing & Diagnostics Head office and Area Served
3.6 Global Key Players of Respiratory Disease Testing & Diagnostics, Product and Application
3.7 Global Key Players of Respiratory Disease Testing & Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Disease Testing & Diagnostics Breakdown Data by Type
4.1 Global Respiratory Disease Testing & Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Respiratory Disease Testing & Diagnostics Forecasted Market Size by Type (2026-2031)
5 Respiratory Disease Testing & Diagnostics Breakdown Data by Application
5.1 Global Respiratory Disease Testing & Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Respiratory Disease Testing & Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Respiratory Disease Testing & Diagnostics Market Size (2020-2031)
6.2 North America Respiratory Disease Testing & Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Respiratory Disease Testing & Diagnostics Market Size by Country (2020-2025)
6.4 North America Respiratory Disease Testing & Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Respiratory Disease Testing & Diagnostics Market Size (2020-2031)
7.2 Europe Respiratory Disease Testing & Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Respiratory Disease Testing & Diagnostics Market Size by Country (2020-2025)
7.4 Europe Respiratory Disease Testing & Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Disease Testing & Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Respiratory Disease Testing & Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Respiratory Disease Testing & Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Respiratory Disease Testing & Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Respiratory Disease Testing & Diagnostics Market Size (2020-2031)
9.2 Latin America Respiratory Disease Testing & Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Respiratory Disease Testing & Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Respiratory Disease Testing & Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Disease Testing & Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Respiratory Disease Testing & Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Respiratory Disease Testing & Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Respiratory Disease Testing & Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Becton Dickinson
11.1.1 Becton Dickinson Company Details
11.1.2 Becton Dickinson Business Overview
11.1.3 Becton Dickinson Respiratory Disease Testing & Diagnostics Introduction
11.1.4 Becton Dickinson Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025)
11.1.5 Becton Dickinson Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Respiratory Disease Testing & Diagnostics Introduction
11.2.4 Abbott Laboratories Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025)
11.2.5 Abbott Laboratories Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Respiratory Disease Testing & Diagnostics Introduction
11.3.4 Abbott Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025)
11.3.5 Abbott Recent Development
11.4 Cepheid
11.4.1 Cepheid Company Details
11.4.2 Cepheid Business Overview
11.4.3 Cepheid Respiratory Disease Testing & Diagnostics Introduction
11.4.4 Cepheid Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025)
11.4.5 Cepheid Recent Development
11.5 Fischer and Paykel
11.5.1 Fischer and Paykel Company Details
11.5.2 Fischer and Paykel Business Overview
11.5.3 Fischer and Paykel Respiratory Disease Testing & Diagnostics Introduction
11.5.4 Fischer and Paykel Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025)
11.5.5 Fischer and Paykel Recent Development
11.6 Futuremed
11.6.1 Futuremed Company Details
11.6.2 Futuremed Business Overview
11.6.3 Futuremed Respiratory Disease Testing & Diagnostics Introduction
11.6.4 Futuremed Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025)
11.6.5 Futuremed Recent Development
11.7 Hoffmann-La Roche
11.7.1 Hoffmann-La Roche Company Details
11.7.2 Hoffmann-La Roche Business Overview
11.7.3 Hoffmann-La Roche Respiratory Disease Testing & Diagnostics Introduction
11.7.4 Hoffmann-La Roche Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025)
11.7.5 Hoffmann-La Roche Recent Development
11.8 Instrumentation Laboratories
11.8.1 Instrumentation Laboratories Company Details
11.8.2 Instrumentation Laboratories Business Overview
11.8.3 Instrumentation Laboratories Respiratory Disease Testing & Diagnostics Introduction
11.8.4 Instrumentation Laboratories Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025)
11.8.5 Instrumentation Laboratories Recent Development
11.9 Medtronic
11.9.1 Medtronic Company Details
11.9.2 Medtronic Business Overview
11.9.3 Medtronic Respiratory Disease Testing & Diagnostics Introduction
11.9.4 Medtronic Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025)
11.9.5 Medtronic Recent Development
11.10 NDD Medical Technologies
11.10.1 NDD Medical Technologies Company Details
11.10.2 NDD Medical Technologies Business Overview
11.10.3 NDD Medical Technologies Respiratory Disease Testing & Diagnostics Introduction
11.10.4 NDD Medical Technologies Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025)
11.10.5 NDD Medical Technologies Recent Development
11.11 Nihon Kohden
11.11.1 Nihon Kohden Company Details
11.11.2 Nihon Kohden Business Overview
11.11.3 Nihon Kohden Respiratory Disease Testing & Diagnostics Introduction
11.11.4 Nihon Kohden Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025)
11.11.5 Nihon Kohden Recent Development
11.12 Philips Medical Systems
11.12.1 Philips Medical Systems Company Details
11.12.2 Philips Medical Systems Business Overview
11.12.3 Philips Medical Systems Respiratory Disease Testing & Diagnostics Introduction
11.12.4 Philips Medical Systems Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025)
11.12.5 Philips Medical Systems Recent Development
11.13 SDI Diagnostics
11.13.1 SDI Diagnostics Company Details
11.13.2 SDI Diagnostics Business Overview
11.13.3 SDI Diagnostics Respiratory Disease Testing & Diagnostics Introduction
11.13.4 SDI Diagnostics Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025)
11.13.5 SDI Diagnostics Recent Development
11.14 Seegene
11.14.1 Seegene Company Details
11.14.2 Seegene Business Overview
11.14.3 Seegene Respiratory Disease Testing & Diagnostics Introduction
11.14.4 Seegene Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025)
11.14.5 Seegene Recent Development
11.15 Smiths Medical
11.15.1 Smiths Medical Company Details
11.15.2 Smiths Medical Business Overview
11.15.3 Smiths Medical Respiratory Disease Testing & Diagnostics Introduction
11.15.4 Smiths Medical Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025)
11.15.5 Smiths Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Respiratory Disease Testing & Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Imaging Test
 Table 3. Key Players of Respiratory Measurement
 Table 4. Key Players of Blood Gas Test
 Table 5. Key Players of Other
 Table 6. Global Respiratory Disease Testing & Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Respiratory Disease Testing & Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Respiratory Disease Testing & Diagnostics Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Respiratory Disease Testing & Diagnostics Market Share by Region (2020-2025)
 Table 10. Global Respiratory Disease Testing & Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Respiratory Disease Testing & Diagnostics Market Share by Region (2026-2031)
 Table 12. Respiratory Disease Testing & Diagnostics Market Trends
 Table 13. Respiratory Disease Testing & Diagnostics Market Drivers
 Table 14. Respiratory Disease Testing & Diagnostics Market Challenges
 Table 15. Respiratory Disease Testing & Diagnostics Market Restraints
 Table 16. Global Respiratory Disease Testing & Diagnostics Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Respiratory Disease Testing & Diagnostics Market Share by Players (2020-2025)
 Table 18. Global Top Respiratory Disease Testing & Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Disease Testing & Diagnostics as of 2024)
 Table 19. Ranking of Global Top Respiratory Disease Testing & Diagnostics Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Respiratory Disease Testing & Diagnostics Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Respiratory Disease Testing & Diagnostics, Headquarters and Area Served
 Table 22. Global Key Players of Respiratory Disease Testing & Diagnostics, Product and Application
 Table 23. Global Key Players of Respiratory Disease Testing & Diagnostics, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Respiratory Disease Testing & Diagnostics Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Respiratory Disease Testing & Diagnostics Revenue Market Share by Type (2020-2025)
 Table 27. Global Respiratory Disease Testing & Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Respiratory Disease Testing & Diagnostics Revenue Market Share by Type (2026-2031)
 Table 29. Global Respiratory Disease Testing & Diagnostics Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Respiratory Disease Testing & Diagnostics Revenue Market Share by Application (2020-2025)
 Table 31. Global Respiratory Disease Testing & Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Respiratory Disease Testing & Diagnostics Revenue Market Share by Application (2026-2031)
 Table 33. North America Respiratory Disease Testing & Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Respiratory Disease Testing & Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Respiratory Disease Testing & Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Respiratory Disease Testing & Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Respiratory Disease Testing & Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Respiratory Disease Testing & Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Respiratory Disease Testing & Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Respiratory Disease Testing & Diagnostics Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Respiratory Disease Testing & Diagnostics Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Respiratory Disease Testing & Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Respiratory Disease Testing & Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Respiratory Disease Testing & Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Respiratory Disease Testing & Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Respiratory Disease Testing & Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Respiratory Disease Testing & Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Becton Dickinson Company Details
 Table 49. Becton Dickinson Business Overview
 Table 50. Becton Dickinson Respiratory Disease Testing & Diagnostics Product
 Table 51. Becton Dickinson Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025) & (US$ Million)
 Table 52. Becton Dickinson Recent Development
 Table 53. Abbott Laboratories Company Details
 Table 54. Abbott Laboratories Business Overview
 Table 55. Abbott Laboratories Respiratory Disease Testing & Diagnostics Product
 Table 56. Abbott Laboratories Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025) & (US$ Million)
 Table 57. Abbott Laboratories Recent Development
 Table 58. Abbott Company Details
 Table 59. Abbott Business Overview
 Table 60. Abbott Respiratory Disease Testing & Diagnostics Product
 Table 61. Abbott Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025) & (US$ Million)
 Table 62. Abbott Recent Development
 Table 63. Cepheid Company Details
 Table 64. Cepheid Business Overview
 Table 65. Cepheid Respiratory Disease Testing & Diagnostics Product
 Table 66. Cepheid Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025) & (US$ Million)
 Table 67. Cepheid Recent Development
 Table 68. Fischer and Paykel Company Details
 Table 69. Fischer and Paykel Business Overview
 Table 70. Fischer and Paykel Respiratory Disease Testing & Diagnostics Product
 Table 71. Fischer and Paykel Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025) & (US$ Million)
 Table 72. Fischer and Paykel Recent Development
 Table 73. Futuremed Company Details
 Table 74. Futuremed Business Overview
 Table 75. Futuremed Respiratory Disease Testing & Diagnostics Product
 Table 76. Futuremed Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025) & (US$ Million)
 Table 77. Futuremed Recent Development
 Table 78. Hoffmann-La Roche Company Details
 Table 79. Hoffmann-La Roche Business Overview
 Table 80. Hoffmann-La Roche Respiratory Disease Testing & Diagnostics Product
 Table 81. Hoffmann-La Roche Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025) & (US$ Million)
 Table 82. Hoffmann-La Roche Recent Development
 Table 83. Instrumentation Laboratories Company Details
 Table 84. Instrumentation Laboratories Business Overview
 Table 85. Instrumentation Laboratories Respiratory Disease Testing & Diagnostics Product
 Table 86. Instrumentation Laboratories Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025) & (US$ Million)
 Table 87. Instrumentation Laboratories Recent Development
 Table 88. Medtronic Company Details
 Table 89. Medtronic Business Overview
 Table 90. Medtronic Respiratory Disease Testing & Diagnostics Product
 Table 91. Medtronic Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025) & (US$ Million)
 Table 92. Medtronic Recent Development
 Table 93. NDD Medical Technologies Company Details
 Table 94. NDD Medical Technologies Business Overview
 Table 95. NDD Medical Technologies Respiratory Disease Testing & Diagnostics Product
 Table 96. NDD Medical Technologies Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025) & (US$ Million)
 Table 97. NDD Medical Technologies Recent Development
 Table 98. Nihon Kohden Company Details
 Table 99. Nihon Kohden Business Overview
 Table 100. Nihon Kohden Respiratory Disease Testing & Diagnostics Product
 Table 101. Nihon Kohden Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025) & (US$ Million)
 Table 102. Nihon Kohden Recent Development
 Table 103. Philips Medical Systems Company Details
 Table 104. Philips Medical Systems Business Overview
 Table 105. Philips Medical Systems Respiratory Disease Testing & Diagnostics Product
 Table 106. Philips Medical Systems Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025) & (US$ Million)
 Table 107. Philips Medical Systems Recent Development
 Table 108. SDI Diagnostics Company Details
 Table 109. SDI Diagnostics Business Overview
 Table 110. SDI Diagnostics Respiratory Disease Testing & Diagnostics Product
 Table 111. SDI Diagnostics Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025) & (US$ Million)
 Table 112. SDI Diagnostics Recent Development
 Table 113. Seegene Company Details
 Table 114. Seegene Business Overview
 Table 115. Seegene Respiratory Disease Testing & Diagnostics Product
 Table 116. Seegene Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025) & (US$ Million)
 Table 117. Seegene Recent Development
 Table 118. Smiths Medical Company Details
 Table 119. Smiths Medical Business Overview
 Table 120. Smiths Medical Respiratory Disease Testing & Diagnostics Product
 Table 121. Smiths Medical Revenue in Respiratory Disease Testing & Diagnostics Business (2020-2025) & (US$ Million)
 Table 122. Smiths Medical Recent Development
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Respiratory Disease Testing & Diagnostics Picture
 Figure 2. Global Respiratory Disease Testing & Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Respiratory Disease Testing & Diagnostics Market Share by Type: 2024 VS 2031
 Figure 4. Imaging Test Features
 Figure 5. Respiratory Measurement Features
 Figure 6. Blood Gas Test Features
 Figure 7. Other Features
 Figure 8. Global Respiratory Disease Testing & Diagnostics Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Respiratory Disease Testing & Diagnostics Market Share by Application: 2024 VS 2031
 Figure 10. Hospitals Case Studies
 Figure 11. Physician Clinics Case Studies
 Figure 12. Clinical Laboratories Case Studies
 Figure 13. Other Case Studies
 Figure 14. Respiratory Disease Testing & Diagnostics Report Years Considered
 Figure 15. Global Respiratory Disease Testing & Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Respiratory Disease Testing & Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Respiratory Disease Testing & Diagnostics Market Share by Region: 2024 VS 2031
 Figure 18. Global Respiratory Disease Testing & Diagnostics Market Share by Players in 2024
 Figure 19. Global Top Respiratory Disease Testing & Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Disease Testing & Diagnostics as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Respiratory Disease Testing & Diagnostics Revenue in 2024
 Figure 21. North America Respiratory Disease Testing & Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Respiratory Disease Testing & Diagnostics Market Share by Country (2020-2031)
 Figure 23. United States Respiratory Disease Testing & Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Respiratory Disease Testing & Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Respiratory Disease Testing & Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Respiratory Disease Testing & Diagnostics Market Share by Country (2020-2031)
 Figure 27. Germany Respiratory Disease Testing & Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Respiratory Disease Testing & Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Respiratory Disease Testing & Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Respiratory Disease Testing & Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Respiratory Disease Testing & Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Respiratory Disease Testing & Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Respiratory Disease Testing & Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Respiratory Disease Testing & Diagnostics Market Share by Region (2020-2031)
 Figure 35. China Respiratory Disease Testing & Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Respiratory Disease Testing & Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Respiratory Disease Testing & Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Respiratory Disease Testing & Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Respiratory Disease Testing & Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Respiratory Disease Testing & Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Respiratory Disease Testing & Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Respiratory Disease Testing & Diagnostics Market Share by Country (2020-2031)
 Figure 43. Mexico Respiratory Disease Testing & Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Respiratory Disease Testing & Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Respiratory Disease Testing & Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Respiratory Disease Testing & Diagnostics Market Share by Country (2020-2031)
 Figure 47. Turkey Respiratory Disease Testing & Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Respiratory Disease Testing & Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Respiratory Disease Testing & Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Becton Dickinson Revenue Growth Rate in Respiratory Disease Testing & Diagnostics Business (2020-2025)
 Figure 51. Abbott Laboratories Revenue Growth Rate in Respiratory Disease Testing & Diagnostics Business (2020-2025)
 Figure 52. Abbott Revenue Growth Rate in Respiratory Disease Testing & Diagnostics Business (2020-2025)
 Figure 53. Cepheid Revenue Growth Rate in Respiratory Disease Testing & Diagnostics Business (2020-2025)
 Figure 54. Fischer and Paykel Revenue Growth Rate in Respiratory Disease Testing & Diagnostics Business (2020-2025)
 Figure 55. Futuremed Revenue Growth Rate in Respiratory Disease Testing & Diagnostics Business (2020-2025)
 Figure 56. Hoffmann-La Roche Revenue Growth Rate in Respiratory Disease Testing & Diagnostics Business (2020-2025)
 Figure 57. Instrumentation Laboratories Revenue Growth Rate in Respiratory Disease Testing & Diagnostics Business (2020-2025)
 Figure 58. Medtronic Revenue Growth Rate in Respiratory Disease Testing & Diagnostics Business (2020-2025)
 Figure 59. NDD Medical Technologies Revenue Growth Rate in Respiratory Disease Testing & Diagnostics Business (2020-2025)
 Figure 60. Nihon Kohden Revenue Growth Rate in Respiratory Disease Testing & Diagnostics Business (2020-2025)
 Figure 61. Philips Medical Systems Revenue Growth Rate in Respiratory Disease Testing & Diagnostics Business (2020-2025)
 Figure 62. SDI Diagnostics Revenue Growth Rate in Respiratory Disease Testing & Diagnostics Business (2020-2025)
 Figure 63. Seegene Revenue Growth Rate in Respiratory Disease Testing & Diagnostics Business (2020-2025)
 Figure 64. Smiths Medical Revenue Growth Rate in Respiratory Disease Testing & Diagnostics Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS